Kusajili – Clinical trials directory

Result of your search per sponsor: Jeroen Janssen, MD, PhD

Woman and Man Max 99 years
Jeroen Janssen, MD, PhD Update Il y a 4 ans

Nilotinib Plus Pegylated Interferon-α2b in CML The purpose of this trial is to assess the effect of switching CML patients, who have been treated with imatinib ≥ 2 years and who have stable detectable molecular residual disease between...

Country None
organs None
Specialty None

unknown

More information